Advertisement
Canada markets close in 5 hours 16 minutes
  • S&P/TSX

    21,722.32
    -151.40 (-0.69%)
     
  • S&P 500

    5,003.99
    -67.64 (-1.33%)
     
  • DOW

    37,773.42
    -687.50 (-1.79%)
     
  • CAD/USD

    0.7295
    -0.0002 (-0.03%)
     
  • CRUDE OIL

    82.22
    -0.59 (-0.71%)
     
  • Bitcoin CAD

    86,950.16
    -2,037.09 (-2.29%)
     
  • CMC Crypto 200

    1,380.34
    -2.23 (-0.16%)
     
  • GOLD FUTURES

    2,344.00
    +5.60 (+0.24%)
     
  • RUSSELL 2000

    1,969.46
    -25.96 (-1.30%)
     
  • 10-Yr Bond

    4.7080
    +0.0560 (+1.20%)
     
  • NASDAQ

    15,453.79
    -258.96 (-1.65%)
     
  • VOLATILITY

    16.84
    +0.87 (+5.45%)
     
  • FTSE

    8,064.96
    +24.58 (+0.31%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • CAD/EUR

    0.6807
    -0.0012 (-0.18%)
     

The past three years for Héroux-Devtek (TSE:HRX) investors has not been profitable

In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market index fund. But its virtually certain that sometimes you will buy stocks that fall short of the market average returns. Unfortunately, that's been the case for longer term Héroux-Devtek Inc. (TSE:HRX) shareholders, since the share price is down 25% in the last three years, falling well short of the market return of around 33%. Shareholders have had an even rougher run lately, with the share price down 17% in the last 90 days. However, one could argue that the price has been influenced by the general market, which is down 12% in the same timeframe.

With that in mind, it's worth seeing if the company's underlying fundamentals have been the driver of long term performance, or if there are some discrepancies.

See our latest analysis for Héroux-Devtek

To quote Buffett, 'Ships will sail around the world but the Flat Earth Society will flourish. There will continue to be wide discrepancies between price and value in the marketplace...' One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.

ADVERTISEMENT

Although the share price is down over three years, Héroux-Devtek actually managed to grow EPS by 9.0% per year in that time. Given the share price reaction, one might suspect that EPS is not a good guide to the business performance during the period (perhaps due to a one-off loss or gain). Or else the company was over-hyped in the past, and so its growth has disappointed.

Since the change in EPS doesn't seem to correlate with the change in share price, it's worth taking a look at other metrics.

With revenue flat over three years, it seems unlikely that the share price is reflecting the top line. There doesn't seem to be any clear correlation between the fundamental business metrics and the share price. That could mean that the stock was previously overrated, or it could spell opportunity now.

The graphic below depicts how earnings and revenue have changed over time (unveil the exact values by clicking on the image).

earnings-and-revenue-growth
earnings-and-revenue-growth

We know that Héroux-Devtek has improved its bottom line lately, but what does the future have in store? So it makes a lot of sense to check out what analysts think Héroux-Devtek will earn in the future (free profit forecasts).

A Different Perspective

While the broader market gained around 0.1% in the last year, Héroux-Devtek shareholders lost 19%. However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. Unfortunately, last year's performance may indicate unresolved challenges, given that it was worse than the annualised loss of 0.3% over the last half decade. We realise that Baron Rothschild has said investors should "buy when there is blood on the streets", but we caution that investors should first be sure they are buying a high quality business. It's always interesting to track share price performance over the longer term. But to understand Héroux-Devtek better, we need to consider many other factors. Case in point: We've spotted 1 warning sign for Héroux-Devtek you should be aware of.

But note: Héroux-Devtek may not be the best stock to buy. So take a peek at this free list of interesting companies with past earnings growth (and further growth forecast).

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on CA exchanges.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.